1335490-31-7

Upstream product

• 1335490-29-3 C₁₆H₂₅N₃O₆S 
• 58032-84-1 (3-nitrophenyl)methanesulfonyl chloride 
• 68076-36-8 1-amino-4-[(tert-butyloxycarbonyl)amino]butane 

Downstream Products

• 1335490-27-1 tert-butyl [4-(((3-((4-chloro-1,3,5-triazin-2-yl)amino)phenyl)methyl)sulfonamido)butyl]carbamate 
• 1335491-07-0 tert-butyl [4-((3-((4-(4-fluoro-2-methoxyphenyl)-1,3,5-triazin-2-yl)amino)phenyl)methylsulfonamido)butyl]carbamate 
• 1335491-10-5 N-(4-aminobutyl)-1-[3-((4-(4-fluoro-2-methoxyphenyl)-1,3,5-triazin-2-yl)amino)phenyl]methanesulfonamide 

Relevant academic research and scientific papers

PHARMACEUTICALLY ACTIVE DISUBSTITUTED TRIAZINE DERIVATIVES

The present invention relates to disubstituted triazine derivatives and/or pharmaceutically acceptable salts thereof, the use of these derivatives as pharmaceutically active agents, especially for the prophylaxis and/or treatment of infectious diseases, including opportunistic diseases, immunological diseases, autoimmune diseases, cardiovascular diseases, cell proliferative diseases, inflammation, erectile dysfunction and stroke, and pharmaceutical compositions containing at least one of said disubstituted triazine derivatives and/or pharmaceutically acceptable salts thereof. Furthermore, the present invention relates to the use of said disubstituted triazine derivatives as inhibitors for a protein kinase. formula (I) wherein R1 is formula (II), formula (III) or formula (IV).